Methods: Non-duplicate isolates (n=118) resistant to cefotaxime (MICs >1 mg/L) were screened by 25 PCR for genes encoding CTX-M extended-spectrum beta-lactamases (ESBLs) and associated ISEcp1-26 like elements, and for genes encoding acquired AmpC, SHV, TEM, VEB, PER and GES beta-27 lactamases. Sequencing was used to identify specific alleles in selected isolates. Carbapenem 28 resistance was sought by ertapenem disc screening. 29
Objectives: To identify the mechanism(s) underlying cefotaxime resistance in 118 of 21,641 (0.55%)non-typhoidal Salmonella enterica collected from humans throughout England and Wales from 23 January 2010 to September 2012. 24
Methods: Non-duplicate isolates (n=118) resistant to cefotaxime (MICs >1 mg/L) were screened by 25 PCR for genes encoding CTX-M extended-spectrum beta-lactamases (ESBLs) and associated ISEcp1-26 like elements, and for genes encoding acquired AmpC, SHV, TEM, VEB, PER and GES beta-27 lactamases. Sequencing was used to identify specific alleles in selected isolates. Carbapenem 28 resistance was sought by ertapenem disc screening. 29
Results: Seventy-nine isolates (0.37% of all referred S. enterica) produced ESBLs, 37 (0.17%) 30 produced CMY-type AmpC enzymes, and one had both enzyme types; the mechanism of cefotaxime 31 resistance in three isolates could not be identified. Group 1 CTX-M genes were identified in 57 32 isolates belonging to 22 serotypes, with CTX-M-1 (n=11), -15 (n=9) and -55/57 (n=8) the most 33 prevalent alleles amongst the 29 (49%) investigated. CTX-M-2 (n=5), -14 (n=5), -8 (n=1) and -65 34 (n=1) were also identified. TEM-52 was identified in two isolates and SHV-12 in seven isolates. 35
There was no evidence of carbapenem resistance. ESBL and AmpC genes were detected in both 36 domestically-acquired and travel-associated salmonellae. Eighty-nine isolates (75%) were multidrug-37 resistant (resistant to ≥3 antimicrobial classes) and 42 (36%) had decreased susceptibility to 38 ciprofloxacin (MICs 0.25 -1 mg/L), with a further 13 isolates (11%) resistant (MICs >1 mg/L). mainly due to production of acquired AmpC and extended-spectrum beta-lactamases (ESBLs). 1 The 50 increased occurrence of these enzymes in Salmonella spp., coupled with decreased susceptibility to 51 quinolones compromises the use of these drugs and is a serious public health issue. Mueller-Hinton agar plates and a 10 µg ertapenem disc (Oxoid, Basingstoke, UK) was added. 71
Inhibition zone diameters ≤ 27 mm after 18 h incubation at 37°C were considered 'resistant' by 72 comparison with positive control strains (not salmonellae) producing NDM-1, KPC, VIM, IMP and 73
OXA-48 carbapenemases. 74

Determination of β-lactamase genotypes 75
Isolates were screened by PCR for the presence of CTX-M, AmpC, TEM, SHV, VEB, PER and GES 76 beta-lactamase genes (primer sequences in Table S1 , available as Supplementary data at JAC Online). 77
Where SHV or TEM enzymes were the sole mechanism identified to explain cefotaxime resistance, 78 ESBL production was confirmed by double-disc synergy test and the alleles were identified by 79 sequencing in most cases. All group 2, 8 and 9 CTX-M genes were identified to allele level by 80 sequencing. Group 1 CTX-M alleles and their upstream genetic environments were investigated by 81 PCR and sequencing using primers specific for ISEcp1-like and IS26-like elements (Table S1) 
in 29 82
(49% of CTX-M producers) isolates representing diverse serotypes. Isolates positive for CIT group 83 genes were subsequently screened for CMY genes by PCR (Table S1 ). OXA-1-like, OXA-2-like, 84
OXA-10-like and PSE-1 genes were sought in isolates for which no other cephalosporin resistance 85 mechanism was detected (Table S1) . 86 87
Results and Discussion 88
One hundred and eighteen (0.55%) human NTS isolates from England and Wales in January 2010 -89 mid-September 2012 were resistant to cefotaxime (MICs >1 mg/L) ( Table 1 ). This indicates a 90 significant increase (P<0.0001 by  2 test with Yates correction) since the last prevalence study in 91
2003
. 3, 4 However, this represents the 2010 European average amongst countries using low 92 breakpoints; Netherlands (0.3%) and Denmark (0.5%) (breakpoint >0.5 mg/L), Ireland (3.1%) and 93
respectively. The prevalence of these genes has increased from 0.03% (15/45,318) known (74 of 118 isolates), ESBL and AmpC genes were associated with both domestically-acquired 99 (n=16, 22%) and travel-associated (n= 58, 78%) NTS infections (Table 1) . 100
CTX-M genes in S. enterica 101
The occurrence of β-lactamase genes in NTS serotypes are detailed in Table 1 and in Supplementary 102 Table S2 and Figure S1 (available at JAC online). The most common resistance mechanisms detected 103
were group 1 CTX-M genes, which were identified in 57 isolates, 29 of which were S. Typhimurium 104 of various phage types and which were often associated with travel to Asia. The other 28 isolates 105 represented 21 serotypes. PCR revealed that group 1 CTX-M genes were linked to an upstream 106 CTX-M-2 alleles were identified in five isolates including 3/6 S. Heidelberg isolates with the 119 same multidrug-resistance type (ASSu). CTX-M-2 was previously described in S. Virchow isolates 120 common to poultry and humans in Europe.
18, 19 CTX-M-14, which was previously described inSpanish NTS, 20 was identified in five isolates from diverse serotypes, one of which was associated 122 with travel to Spain. Multiple cefotaxime resistance mechanisms were identified in three isolates, 123 including one S. Concord isolate that expressed a group 1 CTX-M gene in combination with TEM and 124 SHV-12 and resembled a multidrug-resistant strain associated with Ethiopian adoptees that was 125 previously identified in England and Wales ( Figure S1 and Table S2 
139
The mechanism(s) of cefotaxime resistance in three isolates could not be identified, although two of 140 them were phenotypically positive for an ESBL by the double-disc synergy test. None of the isolates 141 produced PCR products with primers specific for VEB, PER, GES, OXA-1-like, OXA-2-like, OXA-142 10-like and PSE-1 genes. 143
None of the isolates was considered resistant to carbapenems by the ertapenem disc screen 144
used. 145
Eighty-nine (75%) cefotaxime-resistant isolates representing 25 serotypes were multidrug-resistant 148 (MDR; resistant to ≥3 antimicrobial classes, Tables 1 and S2 ). NTS isolates were resistant to 149 sulphonamides (MICs >64 mg/L; 72%), tetracycline (MICs >8 mg/L; 68%), gentamicin (MICs >4 150 mg/L; 35%), amikacin (MICs >4 mg/L; 2%), kanamycin (MICs >16 mg/L; 18%), neomycin (MICs 151 >8 mg/L; 16%), streptomycin (MICs >16 mg/L; 92%), nalidixic acid (MICs >16 mg/L; 31%), 152 chloramphenicol (MICs >8 mg/L; 39%), trimethoprim (MICs >2 mg/L; 25%), furazolidone (MICs >8 153 mg/L; 11%) and colistin (MICs >8 mg/L; 4%). 154
Forty-two NTS (36%) had decreased susceptibility to ciprofloxacin (DSC) (MICs of 0.25 to 1 155 mg/L), with 22 of these retaining susceptibility to nalidixic acid (MICs ≤16 mg/L), indicating the 156 likely presence of a plasmid-mediated quinolone resistance determinant, based on the findings of a 157 previous study. 25 Thirteen NTS (11%) were resistant to ciprofloxacin (MICs >1 mg/L) including four 158 of five S. Kentucky isolates, three of which were associated with travel to Egypt. These isolates are 159 likely to belong to the ciprofloxacin-resistant ST198-X1 international clone, which originated in this 160 country.
26 Three ciprofloxacin-resistant isolates were S. Agona associated with travel to Thailand or 161 the Asian continent (Table S2 ). Co-resistance to fluoroquinolones and extended-spectrum 162 cephalosporins is already a major public health problem in Asia where 9.3% of NTS isolates sampled 163 27 In the present study dual resistance was found in 0.25% of UK NTS isolates. Where 165 travel history was recorded 58% of these isolates had ties to Asia. The high rate (25%) of reduced 166 susceptibility to ceftriaxone in S. Typhimurium throughout Asia was not evident in England and 167 Wales (0.8%). 27 In this study all 13 isolates associated with travel to Thailand were resistant to ≥5 168 antimicrobial classes. S. Typhimurium isolates (88% MDR) were significantly more resistant than S. 169
Enteritidis isolates (35% MDR) (P=0.0004 by Fisher's exact test). Thirty-four percent of all NTS had 170 penta-resistance type ACSSuT including 16 (39%) S. Typhimurium, 15 of which had a group 1 CTX-171 M gene. Twenty-seven (23%) NTS also had decreased susceptibility or resistance to ciprofloxacin 172 (ACSSuTCp), including 12 (29%) S. Typhimurium.
In conclusion, resistance to third-generation cephalosporins in NTS is a growing concern that requires 175 monitoring. The high degree of co-resistance to fluoroquinolones in cefotaxime-resistant isolates 176 compromises treatment of vulnerable patients, although resistance to carbapenems in NTS remains 177 rare. Our data support travel-associated spread of resistant strains to the UK from locally endemic 178 areas. However the epidemiology of resistance is clearly complex and may involve the spread of 179 multidrug resistance plasmids expressing ESBLs and AmpCs between enterobacterial strains and 180 species.
1, 17 The most commonly identified ESBL and AmpC genes in this study have all been 181 identified in E. coli and Salmonella from food animals in Europe and control measures to limit the 182 dissemination of these strains through the food chain are necessary. 
